Arzneiwerk AG VIDA

    Arzneiwerk AG VIDA

    XXETR:TLIK
    - -
    EUR
    - -
    - -
    Arzneiwerk AG VIDA
    XETR:TLIK
    (Deutsche Borse Xetra)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    EUR
    7.16
    5.5
    4.13
    4.24
    3.67
    2.9
    2.2
    2.24
    2.33
    1.8
    1.43
    0.64
    0.43
    0.35
    0.27
    - -
    0.11
    Revenue per Share
    -2.77
    -5.07
    -1.31
    -1.01
    0.5
    -0.61
    -0.49
    1.08
    0.18
    0.38
    1.33
    0.19
    -0.04
    -0.27
    -0.3
    - -
    -0.13
    Basic EPS, GAAP
    -2.76
    -2.06
    -1.46
    -0.24
    -0.6
    -0.09
    -0.73
    -0.44
    -0.2
    -0.32
    -0.23
    -0.23
    -0.05
    - -
    -0.17
    - -
    -0.24
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -0.59
    -5.43
    -6.95
    -7.95
    -7.45
    8
    8
    -7.48
    8
    -2.93
    -1.6
    -0.08
    0.2
    -0.07
    -0.37
    - -
    -0.51
    Book Value per Share
    -0.14
    -2.49
    -2.66
    -3.66
    -3.55
    -4.04
    -4.53
    -3.49
    -3.3
    - -
    - -
    - -
    0.26
    0.06
    - -
    - -
    - -
    Tangible Book Value per Share
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    4
    6
    6
    6
    - -
    6
    Basic Weighted Avg Shares
    20
    16
    12
    12
    11
    8
    6
    7
    7
    5
    4
    3
    3
    2
    2
    1
    1
    Sales/Revenue/Turnover
    -35.32
    -91.95
    -47.81
    -21.5
    -13.97
    -9.84
    -39.96
    -12.62
    -12.77
    -32.85
    52.93
    -3.48
    -8.7
    -70.73
    -108.36
    -91.56
    -7
    Operating Margin (%)
    2
    8
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    -8
    -15
    -4
    -3
    1
    -2
    -1
    3
    1
    1
    4
    1
    - -
    -2
    -2
    -1
    -1
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    0.41
    3.16
    0.18
    13.36
    7.14
    - -
    - -
    - -
    - -
    15.09
    Effective Tax Rate (%)
    -38.77
    -92.13
    -31.74
    -23.71
    13.58
    -21.02
    -22.39
    48.12
    7.67
    21.03
    93.03
    29.26
    -10.01
    -78.41
    -113.39
    -127.02
    -127.02
    Profit Margin (%)
    5
    1
    2
    -1
    1
    - -
    -4
    -5
    -5
    -5
    -1
    1
    - -
    -1
    -2
    - -
    - -
    Working Capital
    6
    9
    10
    10
    10
    10
    9
    5
    4
    5
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    LT Debt
    5
    -7
    -8
    -11
    -10
    -12
    -13
    -10
    -10
    - -
    - -
    - -
    2
    - -
    - -
    - -
    - -
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -96.55
    - -
    2,926.74
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    32.95
    9.73
    10.84
    -105.5
    -34.81
    - -
    - -
    - -
    - -
    -7.71
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    -6.15
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    EUR

    •

    in mil. unless spec.
    Jun'24
    Sep'24
    Dec'24
    ST Debt
    9
    9
    1
    LT Borrowings
    1
    1
    - -
    LT Finance Leases
    1
    1
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    6
    6
    6
    Market Capitalization
    6
    6
    4

    Working Capital

    EUR

    •

    in mil. unless spec.
    Jun'24
    Sep'24
    Dec'24
    Total Current Assets
    9
    9
    - -
    Cash, Cash Equivalents & STI
    1
    1
    - -
    Accounts Receivable, Net
    1
    1
    - -
    Inventories
    7
    5
    - -
    Total Current Liabilities
    16
    15
    1
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    9
    9
    1
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    - -
    Free Cash Flow
    - -
    - -
    29.23%
    Net Income, GAAP
    21.92%
    55.66%
    -55.88%
    Sales/Revenue/Turnover
    -20.15%
    -27.98%
    -60.61%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    20
    20
    19
    -57
    2
    2023
    15
    15
    15
    -43
    2
    2024
    16
    15
    15
    -45
    1

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.01
    -0.03
    -0.04
    - -
    -0.27
    2023
    -0.07
    -0.05
    -0.13
    - -
    -0.3
    2024
    -0.04
    -0.06
    -0.04
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business